Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.55 |
| ▸ | KDM1A | O60341 | 1/20 | 0.48 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.46 |
| ▸ | CDC25B | P30305 | 1/20 | 0.46 |
| ▸ | DGKA | P23743 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 4/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | SNCA | P37840 | 1/20 | 0.38 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.38 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12633729 | 1.00 | PTPN1 (0.55) | PTPN1KDM1APTPN2CDC25BDGKA | |
| SCHEMBL13277409 | 1.00 | PTPN1 (0.55) | PTPN1KDM1APTPN2CDC25BDGKA | |
| SCHEMBL13277667 | 1.00 | PTPN1 (0.55) | PTPN1KDM1APTPN2CDC25BDGKA | |
| SCHEMBL13470688 | 0.95 | PTPN1 (0.51) | PTPN1KDM1APTPN2CDC25BDGKA | |
| SCHEMBL13470692 | 0.95 | PTPN1 (0.51) | PTPN1KDM1APTPN2CDC25BDGKA | |
| SCHEMBL16221416 | 0.95 | PTPN1 (0.51) | PTPN1KDM1APTPN2CDC25BDGKA | |
| SCHEMBL13277817 | 0.91 | PTPN1 (0.56) | PTPN1KDM1APTPN2CDC25BDGKA | |
| SCHEMBL12632808 | 0.91 | PTPN1 (0.56) | PTPN1KDM1APTPN2CDC25BDGKA | |
| SCHEMBL12633036 | 0.91 | PTPN1 (0.56) | PTPN1KDM1APTPN2CDC25BDGKA | |
| SCHEMBL13277417 | 0.91 | PTPN1 (0.56) | PTPN1KDM1APTPN2CDC25BDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210330794-A1 | EXTERNAL PREPARATION COMPRISING NON-LAMELLAR LIQUID CRYSTAL-FORMING LIPID | FARNEX INCORPORATED (JP) | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210330794-A1 | EXTERNAL PREPARATION COMPRISING NON-LAMELLAR LIQUID CRYSTAL-FORMING LIPID | LIPA, LIPC, CETP | PTPN1 931/4885KDM1A 4391/4885PTPN2 991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.